Arkolith/Insider Trading/DNLI/Form 4

Baker Julian

DirectorDenali Therapeutics Inc. (DNLI) · full profile →Form 4 · filed Dec 15, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 11, 2025Buy(P)2.1M$17.49$36.6M26.0M
Dec 11, 2025Buy(P)191K$17.49$3.3M2.3M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-319291) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML